Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001382417 | SCV001581171 | pathogenic | Multiple endocrine neoplasia, type 1 | 2020-03-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Tyr312*) in the MEN1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals with multiple endocrine neoplasia type 1 (PMID: 9215689, 9832038). Loss-of-function variants in MEN1 are known to be pathogenic (PMID: 12112656, 17853334). |